Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades.

Ojamaa K, Veerus P, Baburin A, Everaus H, Innos K.

Cancer Epidemiol. 2019 Oct;62:101566. doi: 10.1016/j.canep.2019.101566. Epub 2019 Jul 19.

PMID:
31326850
2.

Triiodothyronine Reduces Vascular Dysfunction Associated with Hypertension by Attenuating Protein Kinase G/Vasodilator-Stimulated Phosphoprotein Signaling.

Carrillo-Sepulveda MA, Panackal A, Maracheril R, Maddie N, Patel MN, Ojamaa K, Savinova OV, Gerdes AM.

J Pharmacol Exp Ther. 2019 Oct;371(1):88-94. doi: 10.1124/jpet.119.260471. Epub 2019 Jul 12.

PMID:
31300610
3.

Adenylyl Cyclase 6 Mediates Inhibition of TNF in the Inflammatory Reflex.

Tarnawski L, Reardon C, Caravaca AS, Rosas-Ballina M, Tusche MW, Drake AR, Hudson LK, Hanes WM, Li JH, Parrish WR, Ojamaa K, Al-Abed Y, Faltys M, Pavlov VA, Andersson U, Chavan SS, Levine YA, Mak TW, Tracey KJ, Olofsson PS.

Front Immunol. 2018 Nov 27;9:2648. doi: 10.3389/fimmu.2018.02648. eCollection 2018.

4.

A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease.

McPhillips L, Kholwadwala D, Sison CP, Gruber D, Ojamaa K.

Pediatr Cardiol. 2019 Mar;40(3):546-553. doi: 10.1007/s00246-018-2023-4. Epub 2018 Nov 14.

PMID:
30430186
5.

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.

Ojamaa K, Innos K, Baburin A, Everaus H, Veerus P.

BMC Cancer. 2018 Nov 7;18(1):1075. doi: 10.1186/s12885-018-5006-1.

6.

Comparison of Therapeutic Triiodothyronine Versus Metoprolol in the Treatment of Myocardial Infarction in Rats.

Zhang K, Tang YD, Zhang Y, Ojamaa K, Li Y, Saini AS, Carrillo-Sepulveda MA, Rajagopalan V, Gerdes AM.

Thyroid. 2018 Jun;28(6):799-810. doi: 10.1089/thy.2017.0544. Epub 2018 May 7.

7.

Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery.

Pironkova RP, Giamelli J, Seiden H, Parnell VA, Gruber D, Sison CP, Kowal C, Ojamaa K.

Exp Ther Med. 2017 Jul;14(1):228-238. doi: 10.3892/etm.2017.4493. Epub 2017 May 22.

8.

Nicotinic acetylcholine receptor-mediated protection of the rat heart exposed to ischemia reperfusion.

Mavropoulos SA, Khan NS, Levy ACJ, Faliks BT, Sison CP, Pavlov VA, Zhang Y, Ojamaa K.

Mol Med. 2017 Jul;23:120-133. doi: 10.2119/molmed.2017.00091. Epub 2017 Jun 8.

9.

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.

Ojamaa K, Veerus P, Baburin A, Everaus H, Innos K.

Int J Gynecol Cancer. 2017 Jan;27(1):44-49. doi: 10.1097/IGC.0000000000000858.

PMID:
27870707
10.

Thyroid Hormone and Cardioprotection.

Gerdes AM, Ojamaa K.

Compr Physiol. 2016 Jun 13;6(3):1199-219. doi: 10.1002/cphy.c150012. Review.

PMID:
27347890
11.

Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects.

Rajagopalan V, Zhang Y, Ojamaa K, Chen YF, Pingitore A, Pol CJ, Saunders D, Balasubramanian K, Towner RA, Gerdes AM.

PLoS One. 2016 Mar 16;11(3):e0151413. doi: 10.1371/journal.pone.0151413. eCollection 2016.

12.

Combined Administration of Human Ghrelin and Human Growth Hormone Attenuates Organ Injury and Improves Survival in Aged Septic Rats.

Yang WL, Ma G, Zhou M, Aziz M, Yen HT, Marvropoulos SA, Ojamaa K, Wang P.

Mol Med. 2016 Sep;22:124-135. doi: 10.2119/molmed.2015.00255. Epub 2016 Jan 25.

13.

Age influences inflammatory responses, hemodynamics, and cardiac proteasome activation during acute lung injury.

Linge HM, Lee JY, Ochani K, Koga K, Kohn N, Ojamaa K, Powell SR, Miller EJ.

Exp Lung Res. 2015 May;41(4):216-27. doi: 10.3109/01902148.2014.999174. Epub 2015 Apr 6.

14.

Low-dose T₃ replacement restores depressed cardiac T₃ levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus.

Weltman NY, Ojamaa K, Schlenker EH, Chen YF, Zucchi R, Saba A, Colligiani D, Rajagopalan V, Pol CJ, Gerdes AM.

Mol Med. 2014 May 1;20:302-12. doi: 10.2119/molmed.2013.00040.

15.

Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats.

Weltman NY, Ojamaa K, Savinova OV, Chen YF, Schlenker EH, Zucchi R, Saba A, Colligiani D, Pol CJ, Gerdes AM.

Endocrinology. 2013 Jul;154(7):2542-52. doi: 10.1210/en.2012-2087. Epub 2013 Apr 17.

16.

Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.

Koga K, Kenessey A, Ojamaa K.

Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H282-93. doi: 10.1152/ajpheart.00595.2012. Epub 2012 Nov 9.

17.

Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress.

Koga K, Kenessey A, Powell SR, Sison CP, Miller EJ, Ojamaa K.

Antioxid Redox Signal. 2011 Apr 1;14(7):1191-202. doi: 10.1089/ars.2010.3163. Epub 2011 Feb 5.

PMID:
20831446
18.

Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.

Ojamaa K.

Vascul Pharmacol. 2010 Mar-Apr;52(3-4):113-9. doi: 10.1016/j.vph.2009.11.008. Epub 2009 Dec 11. Review.

19.

Macrophage CD74 contributes to MIF-induced pulmonary inflammation.

Takahashi K, Koga K, Linge HM, Zhang Y, Lin X, Metz CN, Al-Abed Y, Ojamaa K, Miller EJ.

Respir Res. 2009 May 4;10:33. doi: 10.1186/1465-9921-10-33.

20.

Macrophage migration inhibitory factor induces cardiomyocyte apoptosis.

Dhanantwari P, Nadaraj S, Kenessey A, Chowdhury D, Al-Abed Y, Miller EJ, Ojamaa K.

Biochem Biophys Res Commun. 2008 Jun 27;371(2):298-303. doi: 10.1016/j.bbrc.2008.04.070. Epub 2008 Apr 24.

21.

N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.

Walsh R, Boyer C, LaCorte J, Parnell V, Sison C, Chowdhury D, Ojamaa K.

J Thorac Cardiovasc Surg. 2008 Jan;135(1):98-105. doi: 10.1016/j.jtcvs.2007.08.012.

22.

Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.

Merchant S, Nadaraj S, Chowdhury D, Parnell VA, Sison C, Miller EJ, Ojamaa K.

Mol Med. 2008 Mar-Apr;14(3-4):124-30.

23.

Lung-derived macrophage migration inhibitory factor in sepsis induces cardio-circulatory depression.

Sakuragi T, Lin X, Metz CN, Ojamaa K, Kohn N, Al-Abed Y, Miller EJ.

Surg Infect (Larchmt). 2007 Feb;8(1):29-40.

24.

Cytokine response in children undergoing surgery for congenital heart disease.

Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D.

Pediatr Cardiol. 2006 Jul-Aug;27(4):408-13. Epub 2006 Jul 6.

PMID:
16830075
25.

Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways.

Kenessey A, Ojamaa K.

J Biol Chem. 2006 Jul 28;281(30):20666-72. Epub 2006 May 22.

26.

Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis.

Lin X, Sakuragi T, Metz CN, Ojamaa K, Skopicki HA, Wang P, Al-Abed Y, Miller EJ.

Shock. 2005 Dec;24(6):556-63.

PMID:
16317387
27.

Nuclear localization of protein kinase C-alpha induces thyroid hormone receptor-alpha1 expression in the cardiomyocyte.

Kenessey A, Sullivan EA, Ojamaa K.

Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H381-9. Epub 2005 Sep 9.

28.
29.

Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.

Chaudhary KW, Rossman EI, Piacentino V 3rd, Kenessey A, Weber C, Gaughan JP, Ojamaa K, Klein I, Bers DM, Houser SR, Margulies KB.

J Am Coll Cardiol. 2004 Aug 18;44(4):837-45.

30.

Interleukin-6 and thyroid hormone metabolism in pediatric cardiac surgery patients.

McMahon CK, Klein I, Ojamaa K.

Thyroid. 2003 Mar;13(3):301-4.

PMID:
12729481
31.

Triiodothyronine-mediated myosin heavy chain gene transcription in the heart.

Danzi S, Ojamaa K, Klein I.

Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2255-62. Epub 2003 Feb 27.

32.

Acute exposure to thyroid hormone increases Na+ current and intracellular Ca2+ in cat atrial myocytes.

Wang YG, Dedkova EN, Fiening JP, Ojamaa K, Blatter LA, Lipsius SL.

J Physiol. 2003 Jan 15;546(Pt 2):491-9.

33.

Role of USF1 phosphorylation on cardiac alpha-myosin heavy chain promoter activity.

Xiao Q, Kenessey A, Ojamaa K.

Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H213-9.

34.

A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease.

Chowdhury D, Ojamaa K, Parnell VA, McMahon C, Sison CP, Klein I.

J Thorac Cardiovasc Surg. 2001 Nov;122(5):1023-5. No abstract available.

35.

Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles.

Shenoy R, Klein I, Ojamaa K.

Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1690-6.

36.

Preserved contractile function despite atrophic remodeling in unloaded rat hearts.

Welsh DC, Dipla K, McNulty PH, Mu A, Ojamaa KM, Klein I, Houser SR, Margulies KB.

Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1131-6.

37.

Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes.

Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA.

J Mol Cell Cardiol. 2001 Apr;33(4):811-24.

PMID:
11273733
38.

Thyroid hormone: targeting the vascular smooth muscle cell.

Klein I, Ojamaa K.

Circ Res. 2001 Feb 16;88(3):260-1. No abstract available.

PMID:
11179190
39.

Thyroid hormone and the cardiovascular system.

Klein I, Ojamaa K.

N Engl J Med. 2001 Feb 15;344(7):501-9. Review. No abstract available.

PMID:
11172193
40.

Thyroid hormone-targeting the heart.

Klein I, Ojamaa K.

Endocrinology. 2001 Jan;142(1):11-2. Review. No abstract available.

PMID:
11145560
41.

Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat.

Ojamaa K, Kenessey A, Shenoy R, Klein I.

Am J Physiol Endocrinol Metab. 2000 Dec;279(6):E1319-24.

42.
43.

Thyroid (neuro)myopathy.

Klein I, Ojamaa K.

Lancet. 2000 Aug 19;356(9230):614. No abstract available.

PMID:
10968432
44.

Thyroid hormone regulation of phospholamban phosphorylation in the rat heart.

Ojamaa K, Kenessey A, Klein I.

Endocrinology. 2000 Jun;141(6):2139-44.

PMID:
10830301
45.
46.

Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes.

Sun ZQ, Ojamaa K, Coetzee WA, Artman M, Klein I.

Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E302-7.

47.

Usefulness of triiodothyronine (T3) treatment after surgery for complex congenital heart disease in infants and children.

Chowdhury D, Parnell VA, Ojamaa K, Boxer R, Cooper R, Klein I.

Am J Cardiol. 1999 Nov 1;84(9):1107-9, A10.

PMID:
10569678
48.

Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific.

Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I.

Endocrinology. 1999 Jul;140(7):3170-6.

PMID:
10385411
49.

Regulation of Na/K-ATPase gene expression by thyroid hormone and hyperkalemia in the heart.

Yalcin Y, Carman D, Shao Y, Ismail-Beigi F, Klein I, Ojamaa K.

Thyroid. 1999 Jan;9(1):53-9.

PMID:
10037077
50.

Thyrotoxicosis and the heart.

Klein I, Ojamaa K.

Endocrinol Metab Clin North Am. 1998 Mar;27(1):51-62. Review.

PMID:
9534027

Supplemental Content

Loading ...
Support Center